Balyasny Asset Management »

Ironwood Pharmaceuticals shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Ironwood Pharmaceuticals shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Ironwood Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ironwood Pharmaceuticals held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ironwood Pharmaceuticals by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $18M 18M 0.98
2024-03-31 $15M 15M 1.02
2023-12-31 $27M 25M 1.09

More positions owned by Balyasny Asset Management

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Warner Bros Discovery Com Ser A Put Option (WBD)
Raytheon Technologies Corp Call Option (RTX)
Select Sector Spdr Tr State Street Fin Call Option (XLFI)
Select Sector Spdr Tr State Street Ene Call Option (XLE)
Lumentum Hldgs Note 0.500% 6/1 (Principal)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Balyasny Asset Management

Top funds holding Ironwood Pharmaceuticals

Context Capital Management
Jpmorgan Chase & Co
Highbridge Capital Management
D. E. Shaw & Co
DeepCurrents Investment Group
Balyasny Asset Management
UBS Group
Zazove Associates
Advisory Services Network
Leucadia National Corporation
Steward Partners Investment Advisory
Brown Trout Management
Wells Fargo & Company

View all funds holding Ironwood Pharmaceuticals